You want to do paediatric ophthalmology? Seriously?
1 August 2017
| Ryan Davies
|
EYE - Neuro-ophthalmology
Completion of Core Training is approaching fast and you begin to wonder three things. One, where do you want to live? Two, is anyone going to be retiring there soon? Three, what subspecialty do you want to do? In an...
An update on idiopathic intracranial hypertension
1 August 2017
| Susan P Mollan, Alex Sinclair
|
EYE - Neuro-ophthalmology
The incidence of Idiopathic intracranial hypertension (IIH) is increasing, likely in line with the worldwide epidemic of obesity. To date, there have been revisions in the terminology used and diagnostic criteria for IIH; these recognise the need to exclude secondary...
Pituitary tumours: why are they so often missed?
1 August 2017
| James F (Barry) Cullen
|
EYE - Neuro-ophthalmology
Part 2: Clinical varieties, anatomical considerations and case report (see also Part 1 and Part 3) For ophthalmologists there are four types of pituitary tumour to be considered, three of which are named according to the hormone secreted, along with...
Under pressure: a tool to aid the non-ophthalmic practitioner in the timely management of acute angle closure
Acute angle closure is a true ophthalmic emergency that mandates timely diagnosis and treatment. The priority in initial management is to lower the intraocular pressure in an expeditious matter using medical treatments. The risk of irreversible glaucomatous optic neuropathy is...
Pituitary tumours: why are they so often missed?
1 April 2017
| James F (Barry) Cullen
|
EYE - Neuro-ophthalmology
Part 1: Introduction, historical background and Edinburgh connections (see also Part 2 and Part 3) Is there any ophthalmologist who has not missed a pituitary tumour? Hopefully this article will help those currently in practice to avoid such an embarrassment,...
Non-arteritic anterior ischaemic optic neuropathy (NA-AION): a review
1 February 2017
| James F (Barry) Cullen
|
EYE - Neuro-ophthalmology
Ischaemic optic neuropathy (ION) is the commonest adult optic neuropathy encountered today in our ageing population, is a common cause of irreversible visual loss and is usually associated with underlying vascular disease. The condition is classified as follows: (a) Anterior...
The refractive index in the eye lens – implications for clinical practice and optical design
1 August 2016
| Barbara K Pierscionek (Prof), Andy T Augousti (Prof)
|
EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
The eye may appear to be a comparatively simple organ and yet its optical system is complex and continues to be a source of investigation and research. The major optical elements are considered to be the cornea and the lens...
Papilloedema: an update
1 June 2016
| James F (Barry) Cullen
|
EYE - Neuro-ophthalmology
Some readers may have seen a recent report in the national newspapers of the case of a teenage girl with persistent severe headache associated with a fatal brain tumour having been undiagnosed despite many consultations with her medical advisers. It...
Neuro-ophthalmic disease patterns in Southeast Asia with particular reference to giant cell arteritis
1 April 2016
| James F (Barry) Cullen, Lakana Kumar Thavaratnam
|
EYE - Neuro-ophthalmology
As indicated in an earlier article in Eye News [1] Dr Cullen was invited in 2000 to the Singapore National Eye Centre (SNEC) as visiting Professor with a specific remit to set up a specialist neuro-ophthalmology service, which was the...
Stem cell therapy for Parkinson’s disease: researching for an effective cure
1 December 2015
| Romina Vuono
|
EYE - Neuro-ophthalmology
Neurodegenerative diseases are characterised by the chronic and progressive loss of neurons, which in turn results in loss of cognitive and physical functions. The World Health Organization has estimated that the disability-adjusted life years lost from neurological disease was about...
NICE drugs: an update on what’s good to go
Treatment options recommended by the National Institute for Health and Care Excellence (NICE) must be readily available for use in the NHS of England and Wales. This article provides an overview of recent guidance from NICE and summary advice issued...
